Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Biomarkers in Breast Cancer: Where Are We and Where Are We Going?Michael J. Duffy, Siun Walsh, Enda W. McDermott and John CrownPolycystic Ovary Syndrome- Epigenetic Mechanisms and Aberrant MicroRNA Ioana R. Ilie and Carmen E. GeorgescuEN2 in Prostate CancerSophie E. McGrath, Agnieszka Michael, Richard Morgan and Hardev Pandha.Cytochrome P450 in Cancer Susceptibility and TreatmentBalraj Mittal, Sonam Tulsyan, Surendra Kumar, Rama Devi Mittal and Gaurav AgarwalThe Importance of Accurately Assessing Renal Function in the Neonate and InfantGuido Filler, Laudelino Lopes and Mark AwukuSystematic Assessment of the Hemolysis Index: Pros and ConsGiuseppe LippiPeroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng and Chao-Ke Tang

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Biomarkers in Breast Cancer: Where Are We and Where Are We Going?Michael J. Duffy, Siun Walsh, Enda W. McDermott and John CrownPolycystic Ovary Syndrome- Epigenetic Mechanisms and Aberrant MicroRNA Ioana R. Ilie and Carmen E. GeorgescuEN2 in Prostate CancerSophie E. McGrath, Agnieszka Michael, Richard Morgan and Hardev Pandha.Cytochrome P450 in Cancer Susceptibility and TreatmentBalraj Mittal, Sonam Tulsyan, Surendra Kumar, Rama Devi Mittal and Gaurav AgarwalThe Importance of Accurately Assessing Renal Function in the Neonate and InfantGuido Filler, Laudelino Lopes and Mark AwukuSystematic Assessment of the Hemolysis Index: Pros and ConsGiuseppe LippiPeroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng and Chao-Ke Tang

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Biomarkers in Breast Cancer: Where Are We and Where Are We Going?Michael J. Duffy, Siun Walsh, Enda W. McDermott and John CrownPolycystic Ovary Syndrome- Epigenetic Mechanisms and Aberrant MicroRNA Ioana R. Ilie and Carmen E. GeorgescuEN2 in Prostate CancerSophie E. McGrath, Agnieszka Michael, Richard Morgan and Hardev Pandha.Cytochrome P450 in Cancer Susceptibility and TreatmentBalraj Mittal, Sonam Tulsyan, Surendra Kumar, Rama Devi Mittal and Gaurav AgarwalThe Importance of Accurately Assessing Renal Function in the Neonate and InfantGuido Filler, Laudelino Lopes and Mark AwukuSystematic Assessment of the Hemolysis Index: Pros and ConsGiuseppe LippiPeroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng and Chao-Ke Tang